Co-Authors
This is a "connection" page, showing publications co-authored by JEAN NICOLAS VAUTHEY and CHING-WEI DAVID TZENG.
Connection Strength
17.592
-
Cancer Surgery Scheduling During and After the COVID-19 First Wave: The MD Anderson Cancer Center Experience. Ann Surg. 2020 08; 272(2):e106-e111.
Score: 0.773
-
Surgical decision-making and prioritization for cancer patients at the onset of the COVID-19 pandemic: A multidisciplinary approach. Surg Oncol. 2020 Sep; 34:182-185.
Score: 0.759
-
Evaluation of New Classifications for Liver Surgery: Can Anatomic Granularity Predict Both Complexity and Outcomes of Hepatic Resection? Ann Surg. 2018 01; 267(1):24-25.
Score: 0.646
-
Postoperative complications and oncologic outcomes after resection of colorectal liver metastases: the importance of staying on track. Ann Surg Oncol. 2013 Aug; 20(8):2457-9.
Score: 0.476
-
Utilizing risk-stratified pathways to personalize post-hepatectomy discharge planning: A contemporary analysis of 1,354 patients. Am J Surg. 2023 Dec 15.
Score: 0.244
-
Correction: Hepatectomy Before Primary Tumor Resection as Preferred Approach for Synchronous Liver Metastases from Rectal Cancer. Ann Surg Oncol. 2023 Sep; 30(9):5405.
Score: 0.239
-
ASO Author Reflections: The Patient First Approach for Synchronous Liver Metastases from Rectal Cancer. Ann Surg Oncol. 2023 09; 30(9):5401-5402.
Score: 0.236
-
Hepatectomy Before Primary Tumor Resection as Preferred Approach for Synchronous Liver Metastases from Rectal Cancer. Ann Surg Oncol. 2023 Sep; 30(9):5390-5400.
Score: 0.235
-
Benchmarks and Geographic Differences in Gallbladder Cancer Surgery: An International Multicenter Study. Ann Surg Oncol. 2023 Aug; 30(8):4904-4911.
Score: 0.234
-
Individual components of post-hepatectomy care pathways have differential impacts on length of stay. Am J Surg. 2022 Oct 01.
Score: 0.225
-
Survival by Number and Sites of Resections of Recurrence after First Curative Resection of Colorectal Liver Metastases. J Gastrointest Surg. 2022 12; 26(12):2503-2511.
Score: 0.224
-
Prospective Study of Perioperative Circulating Tumor DNA Dynamics in Patients Undergoing Hepatectomy for Colorectal Liver Metastases. Ann Surg. 2023 05 01; 277(5):813-820.
Score: 0.221
-
Opioid Discharge Prescriptions After Inpatient Surgery: Risks of Rebound Refills by Length of Stay. J Surg Res. 2022 10; 278:111-118.
Score: 0.219
-
Prospective Implementation of Standardized Post-Hepatectomy Care Pathways to Reduce Opioid Prescription Volume after Inpatient Surgery. J Am Coll Surg. 2022 07 01; 235(1):41-48.
Score: 0.217
-
AJCC 8th edition pathologic nodal staging of resected pancreatic adenocarcinoma predicts survival regardless of treatment sequencing. Surg Oncol. 2022 Mar; 40:101673.
Score: 0.212
-
Neither Surgical Margin Status nor Somatic Mutation Predicts Local Recurrence After R0-intent Resection for Colorectal Liver Metastases. J Gastrointest Surg. 2022 04; 26(4):791-801.
Score: 0.211
-
Improved Survival over Time After Resection of Colorectal Liver Metastases and Clinical Impact of Multigene Alteration Testing in Patients with Metastatic Colorectal Cancer. J Gastrointest Surg. 2022 03; 26(3):583-593.
Score: 0.209
-
Fast-track two-stage hepatectomy by concurrent portal vein embolization at first-stage hepatectomy in hybrid interventional radiology / operating suite. Surg Oncol. 2021 Dec; 39:101648.
Score: 0.208
-
Genomic Sequencing and Insight into Clinical Heterogeneity and Prognostic Pathway Genes in Patients with Metastatic Colorectal?Cancer. J Am Coll Surg. 2021 08; 233(2):272-284.e13.
Score: 0.205
-
Comment on "Stratification of Major Hepatectomies According to Their Outcome Analysis of 2212 Consecutive Open Resections in Patients Without Cirrhosis". Ann Surg. 2022 08 01; 276(2):e134-e135.
Score: 0.202
-
Sustained reduction in discharge opioid volumes through provider education: Results of 1168 cancer surgery patients over 2 years. J Surg Oncol. 2021 Jul; 124(1):143-151.
Score: 0.202
-
Conditional Recurrence-Free Survival after Oncologic Extended Resection for Gallbladder Cancer: An International Multicenter Analysis. Ann Surg Oncol. 2021 May; 28(5):2675-2682.
Score: 0.201
-
Assessing the 5?-Multiplier Calculation to Reduce Discharge Opioid Prescription Volumes After Inpatient Surgery. JAMA Surg. 2020 12 01; 155(12):1166-1167.
Score: 0.198
-
Alteration of FBXW7 is Associated with Worse Survival in Patients Undergoing Resection of Colorectal Liver Metastases. J Gastrointest Surg. 2021 01; 25(1):186-194.
Score: 0.197
-
A New Surveillance Algorithm After Resection of Colorectal Liver Metastases Based on Changes in Recurrence Risk and RAS Mutation Status. J Natl Compr Canc Netw. 2020 11; 18(11):1500-1508.
Score: 0.197
-
Surgical Management of Localized Hepatocellular Carcinoma in Times of Crisis: A Strategic Approach to Resource Utilization. J Hepatocell Carcinoma. 2020; 7:155-158.
Score: 0.195
-
Perceptions of opioid use and prescribing habits in oncologic surgery: A survey of the society of surgical oncology membership. J Surg Oncol. 2020 Nov; 122(6):1066-1073.
Score: 0.192
-
Clinical Factors Associated With Practice Variation in Discharge Opioid Prescriptions After Pancreatectomy. Ann Surg. 2020 07; 272(1):163-169.
Score: 0.192
-
Educating surgical oncology providers on perioperative opioid use: A departmental survey 1 year after the intervention. J Surg Oncol. 2020 Sep; 122(3):547-554.
Score: 0.191
-
COVID-19 outbreak and surgeonsresponse at a Cancer Center in the United States. Glob Health Med. 2020 Apr 30; 2(2):135-137.
Score: 0.190
-
Comprehensive Complication Index Validates Improved Outcomes Over Time Despite Increased Complexity in 3707 Consecutive Hepatectomies. Ann Surg. 2020 04; 271(4):724-731.
Score: 0.189
-
Hepatic resection for breast cancer liver metastases: Impact of intrinsic subtypes. Eur J Surg Oncol. 2020 09; 46(9):1588-1595.
Score: 0.189
-
Anatomic Resection Is Not Required for Colorectal Liver Metastases with RAS Mutation. J Gastrointest Surg. 2020 05; 24(5):1033-1039.
Score: 0.188
-
Hepatic vein embolization after portal vein embolization to induce additional liver hypertrophy in patients with metastatic colorectal carcinoma. Eur Radiol. 2020 Jul; 30(7):3862-3868.
Score: 0.188
-
Opioid-prescribing Practices After Oncologic Surgery: Opportunities for Improvement and a Call to Action. Ann Surg. 2020 02; 271(2):e9-e10.
Score: 0.187
-
Early postoperative drain fluid amylase in risk-stratified patients promotes tailored post-pancreatectomy drain management and potential for accelerated discharge. Surgery. 2020 02; 167(2):442-447.
Score: 0.184
-
Long-term outcomes in patients undergoing resection, ablation, and trans-arterial chemoembolization of hepatocellular carcinoma in the United States: a national cancer database analysis. Glob Health Med. 2019 Oct 31; 1(1):55-60.
Score: 0.183
-
Characteristics of atypical large well-differentiated hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma? HPB (Oxford). 2020 04; 22(4):545-552.
Score: 0.182
-
Comment on Letter to the Editor Regarding "ALPPS Improves Resectability Compared With Conventional Two-stage Hepatectomy in Patients With Advanced Colorectal Liver Metastasis: When Innovation is Not Enough". Ann Surg. 2019 08; 270(2):e35-e36.
Score: 0.180
-
Benefit of Gemcitabine/Nab-Paclitaxel Rescue of Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma After Early Failure of FOLFIRINOX. Pancreas. 2019 07; 48(6):837-843.
Score: 0.179
-
Inpatient Opioid Use After Pancreatectomy: Opportunities for Reducing Initial Opioid Exposure in Cancer Surgery Patients. Ann Surg Oncol. 2019 Oct; 26(11):3428-3435.
Score: 0.179
-
Mutation Status of RAS, TP53, and SMAD4 is Superior to Mutation Status of RAS Alone for Predicting Prognosis after Resection of Colorectal Liver Metastases. Clin Cancer Res. 2019 10 01; 25(19):5843-5851.
Score: 0.179
-
Intraoperative Air Leak Test to Prevent Bile Leak After Right Posterior Sectionectomy with En Bloc Diaphragm Resection for Metastatic Teratoma. Ann Surg Oncol. 2019 Aug; 26(8):2579.
Score: 0.177
-
Conditional Recurrence-Free Survival after Resection of Colorectal Liver Metastases: Persistent Deleterious Association with RAS and TP53 Co-Mutation. J Am Coll Surg. 2019 09; 229(3):286-294.e1.
Score: 0.177
-
Deleterious Effect of RAS and Evolutionary High-risk TP53 Double Mutation in Colorectal Liver Metastases. Ann Surg. 2019 05; 269(5):917-923.
Score: 0.177
-
Educating Surgical Oncology Providers on Perioperative Opioid Use: Results of a Departmental Survey on Perceptions of Opioid Needs and Prescribing Habits. Ann Surg Oncol. 2019 Jul; 26(7):2011-2018.
Score: 0.176
-
Is early-stage pancreatic adenocarcinoma truly early: stage migration on final pathology with surgery-first versus neoadjuvant therapy sequencing. HPB (Oxford). 2019 09; 21(9):1203-1210.
Score: 0.175
-
Contemporary analysis of complications associated with biliary stents during neoadjuvant therapy for pancreatic adenocarcinoma. HPB (Oxford). 2019 06; 21(6):662-668.
Score: 0.172
-
Perioperative blood transfusions for vein resection during pancreaticoduodenectomy for pancreatic adenocarcinoma: Identification of clinical targets for optimization. HPB (Oxford). 2019 07; 21(7):841-848.
Score: 0.172
-
Surgical Resection for Recurrence After Two-Stage Hepatectomy for Colorectal Liver Metastases Is Feasible, Is Safe, and Improves Survival. J Gastrointest Surg. 2019 01; 23(1):84-92.
Score: 0.168
-
Validation of American Joint Committee on Cancer eighth staging system for gallbladder cancer and its lymphadenectomy guidelines. J Surg Res. 2018 10; 230:148-154.
Score: 0.166
-
Vein resection during pancreaticoduodenectomy for pancreatic adenocarcinoma: Patency rates and outcomes associated with thrombosis. J Surg Oncol. 2018 Jun; 117(8):1648-1654.
Score: 0.165
-
SMAD4 gene mutation predicts poor prognosis in patients undergoing resection for colorectal liver metastases. Eur J Surg Oncol. 2018 05; 44(5):684-692.
Score: 0.164
-
Two-Stage Hepatectomy vs One-Stage Major Hepatectomy with Contralateral Resection or Ablation for Advanced Bilobar Colorectal Liver Metastases. J Am Coll Surg. 2018 05; 226(5):825-834.
Score: 0.163
-
Liver resection is justified for patients with bilateral multiple colorectal liver metastases: A propensity-score-matched analysis. Eur J Surg Oncol. 2018 01; 44(1):122-129.
Score: 0.160
-
Long term outcome after resection of liver metastases from squamous cell carcinoma. Eur J Surg Oncol. 2017 Nov; 43(11):2129-2134.
Score: 0.158
-
Neutrophil-to-lymphocyte ratio predicts prognosis after neoadjuvant chemotherapy and resection of intrahepatic cholangiocarcinoma. Surgery. 2017 10; 162(4):752-765.
Score: 0.156
-
Portal Vein Embolization Reduces Postoperative Hepatic Insufficiency Associated with Postchemotherapy Hepatic Atrophy. J Gastrointest Surg. 2018 01; 22(1):60-67.
Score: 0.155
-
SSAT State-of-the-Art Conference: New Frontiers in Liver Surgery. J Gastrointest Surg. 2017 01; 21(1):175-185.
Score: 0.146
-
Positive Impact of Epidural Analgesia on Oncologic Outcomes in Patients Undergoing Resection of Colorectal Liver Metastases. Ann Surg Oncol. 2016 Mar; 23(3):1003-11.
Score: 0.139
-
Treatment sequencing for resectable pancreatic cancer: influence of early metastases and surgical complications on multimodality therapy completion and survival. J Gastrointest Surg. 2014 Jan; 18(1):16-24; discussion 24-5.
Score: 0.121
-
Safety and efficacy of portal vein embolization before planned major or extended hepatectomy: an institutional experience of 358 patients. J Gastrointest Surg. 2014 Jan; 18(1):45-51.
Score: 0.121
-
Morbidity and mortality after pancreaticoduodenectomy in patients with borderline resectable type C clinical classification. J Gastrointest Surg. 2014 Jan; 18(1):146-55; discussion 155-6.
Score: 0.121
-
Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancer. HPB (Oxford). 2014 May; 16(5):430-8.
Score: 0.120
-
Predictors of morbidity and mortality after hepatectomy in elderly patients: analysis of 7621 NSQIP patients. HPB (Oxford). 2014 May; 16(5):459-68.
Score: 0.120
-
Distinct predictors of pre- versus post-discharge venous thromboembolism after hepatectomy: analysis of 7621 NSQIP patients. HPB (Oxford). 2013 Oct; 15(10):773-80.
Score: 0.119
-
Predicting the risks of venous thromboembolism versus post-pancreatectomy haemorrhage: analysis of 13,771 NSQIP patients. HPB (Oxford). 2014 Apr; 16(4):373-83.
Score: 0.119
-
Optimal future liver remnant in patients treated with extensive preoperative chemotherapy for colorectal liver metastases. Ann Surg Oncol. 2013 Aug; 20(8):2493-500.
Score: 0.115
-
Morbidity of staged proctectomy after hepatectomy for colorectal cancer: a matched case-control analysis. Ann Surg Oncol. 2013 Feb; 20(2):482-90.
Score: 0.112
-
Risk of venous thromboembolism outweighs post-hepatectomy bleeding complications: analysis of 5651 National Surgical Quality Improvement Program patients. HPB (Oxford). 2012 Aug; 14(8):506-13.
Score: 0.109
-
Yield of clinical and radiographic surveillance in patients with resected pancreatic adenocarcinoma following multimodal therapy. HPB (Oxford). 2012 Jun; 14(6):365-72.
Score: 0.108
-
Defined clinical classifications are associated with outcome of patients with anatomically resectable pancreatic adenocarcinoma treated with neoadjuvant therapy. Ann Surg Oncol. 2012 Jun; 19(6):2045-53.
Score: 0.107
-
Incidental Ring-hyperenhancing Liver Micronodules at CT Hepatic Arteriography-guided Percutaneous Thermal Ablation of Colorectal Liver Metastases. Radiol Imaging Cancer. 2024 Mar; 6(2):e230099.
Score: 0.062
-
Revisiting the Malignant Masquerade at the Liver Hilum: Have We Made Progress? Ann Surg Oncol. 2024 May; 31(5):3062-3068.
Score: 0.062
-
Development of a Novel Comprehensive Hepatocellular Carcinoma Outcome Prognostic Scoring System With Integration of Imaging Features. Oncologist. 2023 Dec 30.
Score: 0.061
-
Local Therapy Improves Survival for Early Recurrence After Resection of Colorectal Liver Metastases. Ann Surg Oncol. 2024 Apr; 31(4):2547-2556.
Score: 0.061
-
A Practical Guide to Inflow Control, Retraction, and Exposure for Robotic Hepatectomy. Ann Surg Oncol. 2024 Mar; 31(3):1833.
Score: 0.061
-
Treatment Disparities Partially Mediate Socioeconomic- and Race/Ethnicity-Based Survival Disparities in Stage I-II Hepatocellular Carcinoma. Ann Surg Oncol. 2023 Nov; 30(12):7309-7318.
Score: 0.060
-
Incidence of and Risk Factors for Incisional Hernia After Hepatectomy for Colorectal Liver Metastases. J Gastrointest Surg. 2023 11; 27(11):2388-2395.
Score: 0.059
-
Hepatic Metastasectomy in Squamous Cell Carcinoma of the Anal Canal: A Case Series of a Curative Approach. Cancers (Basel). 2023 Jul 31; 15(15).
Score: 0.059
-
Brain Metastases from Biliary Tract Cancer: Case Series and Clinicogenomic Analysis. Oncologist. 2023 04 06; 28(4):327-332.
Score: 0.058
-
Definitive Liver Radiotherapy for Intrahepatic Cholangiocarcinoma with Extrahepatic Metastases. Liver Cancer. 2023 Aug; 12(3):198-208.
Score: 0.058
-
Evaluating the benefit of surgical resection for hepatocellular carcinoma with multifocality or intrahepatic vascular invasion. HPB (Oxford). 2023 Jul; 25(7):758-765.
Score: 0.058
-
Neoadjuvant chemotherapy for high-risk intrahepatic cholangiocarcinoma - does pathologic response mean better outcomes? HPB (Oxford). 2023 04; 25(4):472-480.
Score: 0.057
-
Impact of cumulative operative time on postoperative complication risk in simultaneous resections of colorectal liver metastases and primary tumors. HPB (Oxford). 2023 03; 25(3):347-352.
Score: 0.057
-
Robotic Extended Right Hepatectomy for Colorectal Liver Metastasis. Ann Surg Oncol. 2022 Dec; 29(13):8455.
Score: 0.056
-
Quality of superior mesenteric and hepatic artery dissection in robotic pancreatoduodenectomy for pancreatic cancer. J Hepatobiliary Pancreat Sci. 2023 Jan; 30(1):e1-e2.
Score: 0.056
-
Comparative analysis of opioid use between robotic and open pancreatoduodenectomy. J Hepatobiliary Pancreat Sci. 2023 Apr; 30(4):523-531.
Score: 0.055
-
Lymphadenectomy and margin-negative resection for biliary tract cancer surgery in the United States-Differential technical performance by approach. J Surg Oncol. 2022 Sep; 126(4):658-666.
Score: 0.055
-
Risk-stratified posthepatectomy pathways based upon the Kawaguchi-Gayet complexity classification and impact on length of stay. Surg Open Sci. 2022 Jul; 9:109-116.
Score: 0.055
-
A prospective feasibility study evaluating the 5x-multiplier to standardize discharge prescriptions in cancer surgery patients. Surg Open Sci. 2022 Jul; 9:51-57.
Score: 0.054
-
Ablative liver radiotherapy for unresected intrahepatic cholangiocarcinoma: Patterns of care and survival in the United States. Cancer. 2022 07 01; 128(13):2529-2539.
Score: 0.054
-
Outcomes of Mixed Pathologic Response in Patients with Multiple Colorectal Liver Metastases Treated with Neoadjuvant Chemotherapy and Liver Resection. Ann Surg Oncol. 2022 Aug; 29(8):5156-5164.
Score: 0.054
-
Effect of Co-mutation of RAS and TP53 on Postoperative ctDNA Detection and Early Recurrence after Hepatectomy for Colorectal Liver Metastases. J Am Coll Surg. 2022 04 01; 234(4):474-483.
Score: 0.054
-
Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial. Lancet Gastroenterol Hepatol. 2022 03; 7(3):208-218.
Score: 0.053
-
Benchmarking Outcomes after Ablative Radiotherapy for Molecularly Characterized Intrahepatic Cholangiocarcinoma. J Pers Med. 2021 Dec 01; 11(12).
Score: 0.053
-
Pilot Clinical Trial of Perioperative Durvalumab and Tremelimumab in the Treatment of Resectable Colorectal Cancer Liver Metastases. Clin Cancer Res. 2021 06 01; 27(11):3039-3049.
Score: 0.051
-
Robotic Completion Radical Cholecystectomy with Fluorescence Guidance. Ann Surg Oncol. 2021 Oct; 28(11):6834.
Score: 0.051
-
Preliminary Analysis of Liquid Biopsy after Hepatectomy for Colorectal Liver Metastases. J Am Coll Surg. 2021 07; 233(1):82-89.e1.
Score: 0.050
-
Time to Rethink Upfront Surgery for Resectable Intrahepatic Cholangiocarcinoma? Implications from the Neoadjuvant Experience. Ann Surg Oncol. 2021 Oct; 28(11):6725-6735.
Score: 0.050
-
Lymph node sampling in resectable hepatocellular carcinoma: national practice patterns and predictors of positive lymph nodes. Surg Oncol. 2021 Mar; 36:138-146.
Score: 0.050
-
RAS/TP53 Co-mutation is Associated With Worse Survival After Concurrent Resection of Colorectal Liver Metastases and Extrahepatic Disease. Ann Surg. 2022 08 01; 276(2):357-362.
Score: 0.050
-
Impact of Integrating Insulin-Like Growth Factor 1 Levels into Model for End-Stage Liver Disease Score for Survival Prediction in Hepatocellular Carcinoma Patients. Oncology. 2020; 98(12):836-846.
Score: 0.049
-
Overall Body Composition and Sarcopenia Are Associated with Poor Liver Hypertrophy Following Portal Vein Embolization. J Gastrointest Surg. 2021 02; 25(2):405-410.
Score: 0.047
-
Correction: Impact of epidural analgesia on the systemic biomarker response after hepatic resection. Oncotarget. 2019 Oct 29; 10(59):6397.
Score: 0.046
-
Chemotherapy Versus Chemoradiation as Preoperative Therapy for Resectable Pancreatic Ductal Adenocarcinoma: A Propensity Score Adjusted Analysis. Pancreas. 2019 02; 48(2):216-222.
Score: 0.044
-
Incidental versus non-incidental gallbladder cancer: index cholecystectomy before oncologic re-resection negatively impacts survival in T2b tumors. HPB (Oxford). 2019 08; 21(8):1046-1056.
Score: 0.044
-
Positive cystic duct margin at index cholecystectomy in incidental gallbladder cancer is an important negative prognosticator. Eur J Surg Oncol. 2019 Jun; 45(6):1061-1068.
Score: 0.043
-
Impact of epidural analgesia on the systemic biomarker response after hepatic resection. Oncotarget. 2019 Jan 15; 10(5):584-594.
Score: 0.043
-
Pancreaticoduodenectomy with Mesocaval Shunt for Locally Advanced Pancreatic Adenocarcinoma. Ann Surg Oncol. 2019 Feb; 26(2):652.
Score: 0.043
-
Middle Hepatic Vein Roadmap for a Safe Laparoscopic Right Hepatectomy. Ann Surg Oncol. 2019 Jan; 26(1):296.
Score: 0.043
-
Intrahepatic Recurrence Patterns Predict Survival After Resection of Colorectal Liver Metastases. Ann Surg Oncol. 2019 Jan; 26(1):275-281.
Score: 0.043
-
Conceptual framework of middle hepatic vein anatomy as a roadmap for safe right hepatectomy. HPB (Oxford). 2019 01; 21(1):43-50.
Score: 0.042
-
Loss of muscle mass during preoperative chemotherapy as a prognosticator for poor survival in patients with colorectal liver metastases. Surgery. 2019 02; 165(2):329-336.
Score: 0.042
-
The role of preoperative therapy prior to pancreatoduodenectomy for distal cholangiocarcinoma. Am J Surg. 2019 07; 218(1):145-150.
Score: 0.042
-
Dose escalation of radiotherapy in unresectable extrahepatic cholangiocarcinoma. Cancer Med. 2018 10; 7(10):4880-4892.
Score: 0.042
-
Long-term survival after post-hepatectomy liver failure for colorectal liver metastases. HPB (Oxford). 2019 03; 21(3):361-369.
Score: 0.042
-
RAS Mutation is Associated with Unsalvageable Recurrence Following Hepatectomy for Colorectal Cancer Liver Metastases. Ann Surg Oncol. 2018 Aug; 25(8):2457-2466.
Score: 0.041
-
Preoperative Fluorouracil, Doxorubicin, and Streptozocin for the Treatment of Pancreatic Neuroendocrine Liver Metastases. Ann Surg Oncol. 2018 Jun; 25(6):1709-1715.
Score: 0.041
-
Open Pancreaticoduodenectomy Case Volume Predicts Outcome of Laparoscopic Approach: A Population-based Analysis. Ann Surg. 2018 03; 267(3):552-560.
Score: 0.041
-
Long-Term Survival According to Histology and Radiologic Response to Preoperative Chemotherapy in 126 Patients Undergoing Resection of Non-GIST Sarcoma Liver Metastases. Ann Surg Oncol. 2018 Jan; 25(1):107-116.
Score: 0.040
-
Association of Clinical Factors With a Major Pathologic Response Following Preoperative Therapy for Pancreatic Ductal Adenocarcinoma. JAMA Surg. 2017 Nov 01; 152(11):1048-1056.
Score: 0.040
-
Reduction of Cardiopulmonary/Renal Complications with Serum BNP-Guided Volume Status Management in Posthepatectomy Patients. J Gastrointest Surg. 2018 03; 22(3):467-476.
Score: 0.040
-
Pathologic Response to Preoperative Therapy as a Novel Prognosticator for Ampullary and Duodenal Adenocarcinoma. Ann Surg Oncol. 2017 Dec; 24(13):3954-3963.
Score: 0.040
-
Pathological diaphragmatic invasion by colorectal liver metastases is associated with RAS mutation, peritoneal recurrence and worse survival. HPB (Oxford). 2018 01; 20(1):57-63.
Score: 0.040
-
Operative and short-term oncologic outcomes of laparoscopic versus open liver resection for colorectal liver metastases located in the posterosuperior liver: a propensity score matching analysis. Surg Endosc. 2018 04; 32(4):1776-1786.
Score: 0.040
-
Extended Lymphadenectomy Is Required for Incidental Gallbladder Cancer Independent of Cystic Duct Lymph Node Status. J Gastrointest Surg. 2018 01; 22(1):43-51.
Score: 0.039
-
Tips and tricks of splenic vessel preservation during laparoscopic distal pancreatectomy. Surg Endosc. 2018 04; 32(4):2149-2150.
Score: 0.039
-
Effective Laparoscopic Management Lymph Node Dissection for Gallbladder Cancer. Ann Surg Oncol. 2017 Jul; 24(7):1852.
Score: 0.038
-
Borderline operability in hepatectomy patients is associated with higher rates of failure to rescue after severe complications. J Surg Oncol. 2017 Mar; 115(3):337-343.
Score: 0.037
-
Systematic use of an intraoperative air leak test at the time of major liver resection reduces the rate of postoperative biliary complications. J Am Coll Surg. 2013 Dec; 217(6):1028-37.
Score: 0.030